ArticleOncology letters2013

Dasatinib inhibits primary melanoma cell proliferation through morphology-dependent disruption of Src-ERK signaling.

Jianghong Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.